Allergic rhinitis (AR) is a frequent disease characterized by type 2 inflammation and typical symptoms. Dysregulation of the immune system, sustained by defective T regulatory cells, leads to type 2 inflammation, mainly concerning eosinophil infiltration of the nasal mucosa. In addition, dysbiosis of intestinal and upper airway microbiota is detectable in many AR patients. Therefore, probiotic supplementation may be a valuable therapeutic option for managing AR patients. Several studies investigated this issue. Interesting outcomes originated from randomized controlled trials. Even though there is no complete agreement about the use of probiotics in AR, adequate evidence suggests their potential use as an add-on strategy in managing patients with AR.

Progress on probiotics as add-on therapy for allergic rhinitis / G. Ciprandi, M. Miraglia del Giudice, L. Drago. - In: REVUE FRANÇAISE D'ALLERGOLOGIE. - ISSN 1877-0320. - 64:2(2024), pp. 103766.1-103766.7. [10.1016/j.reval.2023.103766]

Progress on probiotics as add-on therapy for allergic rhinitis

L. Drago
Ultimo
2024

Abstract

Allergic rhinitis (AR) is a frequent disease characterized by type 2 inflammation and typical symptoms. Dysregulation of the immune system, sustained by defective T regulatory cells, leads to type 2 inflammation, mainly concerning eosinophil infiltration of the nasal mucosa. In addition, dysbiosis of intestinal and upper airway microbiota is detectable in many AR patients. Therefore, probiotic supplementation may be a valuable therapeutic option for managing AR patients. Several studies investigated this issue. Interesting outcomes originated from randomized controlled trials. Even though there is no complete agreement about the use of probiotics in AR, adequate evidence suggests their potential use as an add-on strategy in managing patients with AR.
No
English
Add-on treatment; Allergic rhinitis; Immune system; Modulation; Probiotics
Settore MED/07 - Microbiologia e Microbiologia Clinica
Articolo
Esperti anonimi
Pubblicazione scientifica
Goal 3: Good health and well-being
2024
Elsevier Masson s.r.l.
64
2
103766
1
7
7
Pubblicato
Periodico con rilevanza internazionale
scopus
Aderisco
info:eu-repo/semantics/article
Progress on probiotics as add-on therapy for allergic rhinitis / G. Ciprandi, M. Miraglia del Giudice, L. Drago. - In: REVUE FRANÇAISE D'ALLERGOLOGIE. - ISSN 1877-0320. - 64:2(2024), pp. 103766.1-103766.7. [10.1016/j.reval.2023.103766]
reserved
Prodotti della ricerca::01 - Articolo su periodico
3
262
Article (author)
Periodico con Impact Factor
G. Ciprandi, M. Miraglia del Giudice, L. Drago
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S1877032023004906-main.pdf

accesso riservato

Descrizione: Literature review
Tipologia: Publisher's version/PDF
Dimensione 717.88 kB
Formato Adobe PDF
717.88 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/1050562
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact